Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Psychiatry Clear all

Conditions: Anxiety
Interventions: Psilocybin (drug), Niacin, MRI; Drug · Other · Diagnostic Test
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Torrance, California

Conditions: COVID-19
Interventions: No intervention; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 12,566 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Anxiety Depression, Aneurysm Cerebral, Mental Health Wellness 1
Interventions: Clipping, Endovascular embolization, Surveillance imaging; Procedure · Diagnostic Test
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Behavioral and Psychiatric Symptoms of Dementia
Interventions: Not listed
Lead sponsor: Tabula Rasa HealthCare; Industry
Eligibility: 55 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Moorestown, New Jersey

Conditions: Suicidal Ideation
Interventions: Mental Health Treatment; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 12 Years to 18 Years
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: Queens, New York • Cincinnati, Ohio • Columbus, Ohio + 1 more

Conditions: Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder, REM Sleep Behavior Disorder, REM Sleep Measurement, Insomnia, Insomnia Related to Specified Disorder, Insomnia Due to Other Mental Disorder, Insomnia Comorbid to Psychiatric Disorder, Insomnia Due to Anxiety and Fear, Insomnia Related to Another Mental Condition, Insomnia Disorders, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, Post Trauma Nightmares, PTSD - Post Traumatic Stress Disorder, Sleep Quality, Anesthesia, Anxiety, Depression, Mental Health, Alzheimer Disease or Associated Disorder, Parkinsons, Circadian Rhythm, Circadian Dysregulation, PTSD, Post-Traumatic, Post-Traumatic Stress Disorder Complex, Military Combat Stress Reaction, Sleep, Military Activity, Veterans, Shift Work Sleep Disorder, Menopause Related Conditions, Pain, Cancer Pain, Athletes
Interventions: PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca, Continuous EEG Monitoring; Procedure · Drug · Device
Lead sponsor: Nyree Penn; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Aventura, Florida

Conditions: Posttraumatic Stress Disorder
Interventions: Reminder Focused Positive Psychiatry, attentional control condition (group process); Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 11 Years to 15 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Smoking Cessation
Interventions: Opt-Out Reminder, Opt-In Reminder; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Convulsion, Non-Epileptic, Conversion Disorder, Depression, Stress Disorders, Post-Traumatic
Interventions: sertraline, placebo; Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years to 95 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Suicide, Attempted, Suicidal Ideation
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hepatitis C, Substance Use Disorders, Mental Disorder
Interventions: psychosocial intervention; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 70 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Tobacco Smoking, Psychiatric Disorder, Psychiatric Hospitalization
Interventions: Acceptance and Commitment Therapy, Enhanced Usual Care; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Tobacco Use Cessation, Tobacco Use Disorder
Interventions: stage-tailored intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Head Injuries, Closed
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 0 Years to 12 Years
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 4
States / cities: La Jolla, California • Dallas, Texas • Houston, Texas

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Metabolic Syndrome X
Interventions: Aripiprazole; Drug
Lead sponsor: New Mexico VA Healthcare System; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Post-Traumatic Stress Disorders, Stress Disorders, Combat Disorders
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: San Antonio, Texas

Conditions: Psychiatric Problem
Interventions: $AFE; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 65 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: PTSD (Childbirth-Related), Severe Maternal Morbidity, Depression - Major Depressive Disorder, Anxiety
Interventions: Virtual maternal fetal medicine debriefing consult; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Adolescent Well-Being, Mental Disorders, Severe
Interventions: Not listed
Lead sponsor: Outcome Referrals, Inc.; Industry
Eligibility: 12 Years to 18 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Framingham, Massachusetts

Conditions: Hepatitis C, Medication Adherence
Interventions: Intensive Models (mDOT and CGT) of HCV Care; Other
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Obsessive Compulsive Disorder (OCD), Bipolar Disorders, Major Depressive Disorder, Post-Traumatic Stress Disorder, PTSD, Generalized Anxiety Disorder (GAD)
Interventions: Not listed
Lead sponsor: Psyrin Inc.; Industry
Eligibility: 18 Years to 68 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Sunnyvale, California • New York, New York

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Obesity, Vitamin D Deficiency, Psychosis, Schizophrenia, Schizoaffective Disorder
Interventions: Ergocalciferols; Drug
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 10 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Major Depression, Posttraumatic Stress Disorders, Anxiety Disorders
Interventions: telephone care; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: White River Junction, Vermont

Search by objective public record fields.

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

COVID-19 & Psychiatry: A Retrospective Chart Review

Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)

The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

Observational Study to Compare Outcomes of Different Psychiatric Treatment of Suicidal Adolescents

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry

Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

Treatments for Psychogenic Nonepileptic Seizures (NES)

Natural History of Hopelessness, Suicidality, and Optimism in Psychiatric Inpatients Following Discharge

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

Acceptance and Commitment Therapy for Tobacco Cessation Among Psychiatric Partial Hospital Patients

Treating Tobacco Dependence in Inpatient Psychiatry - 1

Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings

Improving Money Management Skills for Veterans With Psychiatric Disabilities

Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity

Adolescents' Well-being in Community-based Treatment Versus Residential Treatment

Intensive Models of HCV Care for Injection Drug Users

Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions

Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism

Vitamin D Supplementation in Psychiatric Illnesses

Telephone Care as a Substitute for Routine Psychiatric Medication